共 270 条
[1]
Buzdar AU(1985)Early and delayed clinical cardiotoxicity of doxorubicin Cancer 55 2761-2765
[2]
Marcus C(2003)Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2869-2879
[3]
Smith TL(1998)Doxorubicin-induced cardiomyopathy N Engl J Med 339 900-905
[4]
Blumenschein GR(2001)Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study J Clin Oncol: Off J Am Soc Clin Oncol 19 191-196
[5]
Swain SM(1979)Risk factors for doxorubicin-induced congestive heart failure Ann Intern Med 91 710-717
[6]
Whaley FS(2004)Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the north central cancer treatment group N9831 intergroup adjuvant trial J Clin Oncol: Off J Am Soc Clin Oncol 22 3700-3704
[7]
Ewer MS(2007)Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation Int J Nanomed 2 567-583
[8]
Singal PK(2005)Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study J Clin Oncol: Off J Am Soc Clin Oncol 23 8597-8605
[9]
Iliskovic N(2010)Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? J Am Coll Cardiol 56 1644-1650
[10]
Kremer LC(2011)HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies Exp Rev Anticancer Ther 11 263-275